Grace Therapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Grace Therapeutics, Inc. (GRCE) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.63 million for the 3-month period ending 2020-03-31, per its 10-K filed 2020-06-29.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-06-29
- Grace Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$2.63M, a 125.18% decline year-over-year.
- Grace Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $10.45M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month |
|---|---|
| 2020-03-31 | -$2.63M 10-K · filed 2020-06-29 |
| 2019-03-31 | $10.45M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |